Ticker Details
Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
IPO Date:	February 22, 2000
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$333.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 3.87%
Avg Daily Range (30 D):	$0.22 | 2.96%
Avg Daily Range (90 D):	$0.22 | 3.38%

Institutional Daily Volume
Avg Daily Volume:	2.17M
Avg Daily Volume (30 D):	.45M
Avg Daily Volume (90 D):	.45M

Trade Size
Avg Trade Size (Sh.):	186
Avg Trade Size (Sh.) (30 D):	98
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	443
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$.62M
Avg Institutional Trade (90 D):	$1.34M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.41M
Avg Closing Trade (30 D):	$2.79M
Avg Closing Trade (90 D):	$2.79M
Avg Closing Volume:	82.35K

News

Oct 7, 2025 @ 5:17 PM Senseonics Tumbles As Q3 Results And Split Hit Sto... Source: Lekha Gupta

May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A

May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research

Jan 8, 2025 @ 11:12 PM Senseonics Holdings, Inc. Announces Business Updat... Source: N/A

Sep 17, 2024 @ 11:00 AM Eversense 365 Receives FDA Clearance: The Worldââ... Source: Senseonics Holdings, Inc. And Ascensia Diabetes Care

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.74	$-.43	$-.02
Diluted EPS	$.74	$-.43	$-.02
Revenue	$29.3M	$8.1M	$6.65M
Gross Profit	$12.05M	$3.47M	$3.12M
Net Income / Loss	$-63.77M	$-19.53M	$-14.5M
Operating Income / Loss	$-61.68M	$-19.6M	$-14.32M
Cost of Revenue	$17.25M	$4.63M	$3.53M
Net Cash Flow	$7.35M	$2.94M	$-7.79M
PE Ratio	11.00

Splits
Oct 20, 2025	1:20
Nov 10, 2015	12:1